Break it Down: Quick access to quick ED fix from LTR Pharma

Link copied to
clipboard

Stockhead’s Break it Down brings you today’s leading market news in under 90 seconds.

In this episode, host Sarah Hughan tells all on LTR Pharma’s (ASX:LTP) online healthcare platform for Aussie men to access Spontan.

Spontan is a novel nasal spray designed to treat erectile dysfunction, and recent trials have shown a faster absorption than oral treatment.

Tune in to get the latest.

While LTR Pharma is a Stockhead advertiser, it did not sponsor this content.

share

• 
• 
• 
• 

Link copied to
clipboard

SUBSCRIBE

Get the latest Stockhead news delivered free to your inbox.

Name*

Email*

This field is hidden when viewing the form

Email Lists

Morning Update

Lunch Update

Market Close Update

Weekend Update

Spotlight

Email

This field is for validation purposes and should be left unchanged.

It's free. Unsubscribe whenever you want.

By proceeding, you confirm you understand that we handle personal information in accordance with our Privacy Policy.

You might be interested in

Long Shortz

Long Shortz with LTR Pharma: Erectile dysfunction help just a spray away

August 23, 2024 | Stockhead TV

Break It Down

Break it Down: LTR Pharma prescribes ED spray under TGA scheme

August 6, 2024 | Stockhead TV

Break It Down

Break it Down: LTR Pharma flexes SPONTAN spray success

June 7, 2024 | Stockhead TV